Literature DB >> 24878361

A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ.

Remo Guerrini1, Erika Marzola2, Claudio Trapella3, Michela Pela'3, Stefano Molinari4, Maria Camilla Cerlesi4, Davide Malfacini4, Anna Rizzi4, Severo Salvadori2, Girolamo Calo'4.   

Abstract

Branched peptides have been found to be useful in several research fields however their synthesis and purification is complicated. Here we present a novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ (N/OFQ). Three N/OFQ tetra branched derivatives were prepared using novel cores (PWT1, PWT2 and PWT3) containing a maleimido moiety. [Cys(18)]N/OFQ-NH2 was linked to the cores via thiol-Michael reaction characterized by high yield and purity of the desired final product. In the electrically stimulated mouse vas deferens PWT-N/OFQ derivatives mimicked the inhibitory action of the natural sequence showing similar maximal effects and 3 fold higher potencies. The NOP selective antagonist SB-612111 antagonized the effects of N/OFQ and PWT derivatives with similar pKB values (8.02-8.48). In vivo after supraspinal administration PWT2-N/OFQ stimulated food intake in mice mimicking the action of N/OFQ. Compared to the natural peptide PWT2-N/OFQ was 40 fold more potent and elicited larger effects. These findings suggest that the PWT chemical strategy can be successfully applied to biologically active peptides to generate, with unprecedented high purity and yield, tetra branched derivatives displaying an in vitro pharmacological profile similar to that of the natural sequence associated, in vivo, to increased potency and effectiveness.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Branched peptide; In vivo activity; Nociceptin/orphanin FQ

Mesh:

Substances:

Year:  2014        PMID: 24878361     DOI: 10.1016/j.bmc.2014.05.005

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  14 in total

1.  Spinal antinociceptive effects of the novel NOP receptor agonist PWT2-nociceptin/orphanin FQ in mice and monkeys.

Authors:  A Rizzi; D D Sukhtankar; H Ding; K Hayashida; C Ruzza; R Guerrini; G Calò; M C Ko
Journal:  Br J Pharmacol       Date:  2015-05-12       Impact factor: 8.739

2.  Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt1]N/OFQ(1-13).

Authors:  Maria Camilla Cerlesi; Huiping Ding; Mark F Bird; Norikazu Kiguchi; Federica Ferrari; Davide Malfacini; Anna Rizzi; Chiara Ruzza; David G Lambert; Mei-Chuan Ko; Girolamo Calo; Remo Guerrini
Journal:  Eur J Pharmacol       Date:  2016-11-19       Impact factor: 4.432

Review 3.  Nociceptin/Orphanin FQ Peptide Receptor-Related Ligands as Novel Analgesics.

Authors:  Norikazu Kiguchi; Huiping Ding; Shiroh Kishioka; Mei-Chuan Ko
Journal:  Curr Top Med Chem       Date:  2020       Impact factor: 3.295

4.  In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives.

Authors:  A Rizzi; D Malfacini; M C Cerlesi; C Ruzza; E Marzola; M F Bird; D J Rowbotham; S Salvadori; R Guerrini; D G Lambert; G Calo
Journal:  Br J Pharmacol       Date:  2014-09       Impact factor: 8.739

Review 5.  Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems.

Authors:  Lawrence Toll; Michael R Bruchas; Girolamo Calo'; Brian M Cox; Nurulain T Zaveri
Journal:  Pharmacol Rev       Date:  2016-03-08       Impact factor: 25.468

Review 6.  Comprehensive overview of biased pharmacology at the opioid receptors: biased ligands and bias factors.

Authors:  Jolien De Neve; Thomas M A Barlow; Dirk Tourwé; Frédéric Bihel; Frédéric Simonin; Steven Ballet
Journal:  RSC Med Chem       Date:  2021-04-21

7.  In vitro and in vivo pharmacological characterization of a neuropeptide S tetrabranched derivative.

Authors:  Chiara Ruzza; Anna Rizzi; Davide Malfacini; Alice Pulga; Salvatore Pacifico; Severo Salvadori; Claudio Trapella; Rainer K Reinscheid; Girolamo Calo; Remo Guerrini
Journal:  Pharmacol Res Perspect       Date:  2015-01-05

8.  Characterisation of the Novel Mixed Mu-NOP Peptide Ligand Dermorphin-N/OFQ (DeNo).

Authors:  Mark F Bird; Maria Camilla Cerlesi; Mark Brown; Davide Malfacini; Vanessa Vezzi; Paola Molinari; Laura Micheli; Lorenzo Di Cesare Mannelli; Carla Ghelardini; Remo Guerrini; Girolamo Calò; David G Lambert
Journal:  PLoS One       Date:  2016-06-07       Impact factor: 3.240

9.  Use of a Novel Peptide Welding Technology Platform for the Development of B- and T-Cell Epitope-Based Vaccines.

Authors:  Francesco Nicoli; Salvatore Pacifico; Eleonora Gallerani; Erika Marzola; Valentina Albanese; Valentina Finessi; Sian Llewellyn-Lacey; David A Price; Victor Appay; Peggy Marconi; Remo Guerrini; Antonella Caputo; Riccardo Gavioli
Journal:  Vaccines (Basel)       Date:  2021-05-19

10.  Pharmacological Profile of Nociceptin/Orphanin FQ Receptors Interacting with G-Proteins and β-Arrestins 2.

Authors:  D Malfacini; C Ambrosio; M C Gro'; M Sbraccia; C Trapella; R Guerrini; M Bonora; P Pinton; T Costa; G Calo'
Journal:  PLoS One       Date:  2015-08-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.